MD Stock Price Chart More Charts

MD Price/Volume Stats

Mednax, Inc. (MD) Company Bio

MEDNAX Inc. provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company was founded in 1979 and is based in Sunrise, Florida.

MD Price Forecast Based on DCF Valuation

We started the process of determining a valid price forecast for Mednax Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Mednax Inc ranked in the 35st percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Mednax Inc, consider:

• The stock's equity weight, or the proportion of capital from equity relative to debt, is 52. Notably, its equity weight is greater than just 13.17% of US equities in the Healthcare sector yielding a positive free cash flow.
• Its compound free cash flow growth rate, as measured over the past 5.51 years, is -0.03% -- higher than merely 24.99% of stocks in our DCF forecasting set.
• Mednax Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -12.02. This coverage rate is greater than that of merely 5.43% of stocks we're observing for the purpose of forecasting via discounted cash flows.

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MD, try IQV, CHE, LHCG, MDT, and NUVA.